European public healthcare systems achieve superior macroeconomic efficiency and health outcomes compared to highly privatized market-based models.

Empirical data demonstrates a stark divergence in allocative efficiency between public European frameworks and the privatized United States model. In 2019, wealthy European nations averaged a healthcare expenditure of $5,505 per capita, roughly half of the $11,072 spent per capita in the US. Despite this significantly lower financial footprint, European systems consistently report superior public health metrics, including higher life expectancy and lower infant mortality rates, owing to broad risk-pooling and universal access.